These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acute pancreatitis in association with cytosine arabinoside therapy. Altman AJ; Dinndorf P; Quinn JJ Cancer; 1982 Apr; 49(7):1384-6. PubMed ID: 6949626 [TBL] [Abstract][Full Text] [Related]
3. Serum amylase and lipase in the evaluation of acute abdominal pain. Chase CW; Barker DE; Russell WL; Burns RP Am Surg; 1996 Dec; 62(12):1028-33. PubMed ID: 8955242 [TBL] [Abstract][Full Text] [Related]
4. [Importance of the delay in the serum determination of amylase, lipase and isoamylase P3 in the diagnosis of acute pancreatitis]. Navarro S; Aused R; Elena M; Casals E; García-Pugés AM; Adrián MJ; Ballesta AM; Vilar Bonet J Rev Clin Esp; 1987 Nov; 181(7):368-71. PubMed ID: 2447617 [No Abstract] [Full Text] [Related]
5. Small-dose cytosine arabinoside in the treatment of elderly patients with acute leukemia and refractory anemia with excess of blast. Satou Y; Kubota T; Yonekura S; Noguchi K; Oobayashi Y; Nagao T; Arimori S Tokai J Exp Clin Med; 1986 Oct; 11(4):249-54. PubMed ID: 3617109 [TBL] [Abstract][Full Text] [Related]
6. The lipase to amylase ratio in acute pancreatitis. King LG; Seelig CB; Ranney JE Am J Gastroenterol; 1995 Jan; 90(1):67-9. PubMed ID: 7528469 [TBL] [Abstract][Full Text] [Related]
7. The cytosine arabinoside (Ara-C) syndrome. Castleberry RP; Crist WM; Holbrook T; Malluh A; Gaddy D Med Pediatr Oncol; 1981; 9(3):257-64. PubMed ID: 6941069 [TBL] [Abstract][Full Text] [Related]
8. The admission serum lipase:amylase ratio differentiates alcoholic from nonalcoholic acute pancreatitis. Tenner SM; Steinberg W Am J Gastroenterol; 1992 Dec; 87(12):1755-8. PubMed ID: 1280405 [TBL] [Abstract][Full Text] [Related]
9. Acute hyperlipidemic pancreatitis accompanied by chylous ascites with normal amylase and lipase in pregnancy. Yang L; Zhao Z; Zhou K; Zhang Y J Clin Lipidol; 2017; 11(4):1091-1094. PubMed ID: 28826568 [TBL] [Abstract][Full Text] [Related]
10. [Study on the inhibitory effect of oral granisetron against nausea/vomiting induced by cytosine arabinoside containing chemotherapy for tumors in the hematopoietic organs]. Matsuishi H; Harada M; Gondo H; Otsuka T; Teshima T; Yamano Y; Omori F; Shibuya T; Yamazaki K; Taniguchi S Gan To Kagaku Ryoho; 1993 Aug; 20(10):1339-48. PubMed ID: 8394061 [TBL] [Abstract][Full Text] [Related]
12. Asymptomatic elevation of serum lipase and amylase in conjunction with Crohn's disease and ulcerative colitis. Bokemeyer B Z Gastroenterol; 2002 Jan; 40(1):5-10. PubMed ID: 11803494 [TBL] [Abstract][Full Text] [Related]
14. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology. Early AP; Preisler HD; Slocum H; Rustum YM Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642 [TBL] [Abstract][Full Text] [Related]
15. [Intermediate- and high-dose cytosine arabinoside therapy in acute refractory leukemia]. Ohshima A; Yoshida K; Sato T; Miyazaki S; Yanagisawa M; Nakayama Y; Takahashi T; Mamiya S; Fukusima Y; Miura AB Gan To Kagaku Ryoho; 1987 Jan; 14(1):192-5. PubMed ID: 3800405 [TBL] [Abstract][Full Text] [Related]
17. Continuous infusion of high-dose cytosine arabinoside for treatment of childhood acute leukemia and non-Hodgkin's lymphoma in relapse. Jones GR; Ettinger LJ Semin Oncol; 1985 Jun; 12(2 Suppl 3):150-4. PubMed ID: 3874431 [No Abstract] [Full Text] [Related]
18. Pharmacology studies of 1-beta-D-arabinofuranosylcytosine in pediatric patients with leukemia and lymphoma after a biochemically optimal regimen of loading bolus plus continuous infusion of the drug. Avramis VI; Weinberg KI; Sato JK; Lenarsky C; Willoughby ML; Coates TD; Ozkaynak MF; Parkman R Cancer Res; 1989 Jan; 49(1):241-7. PubMed ID: 2908850 [TBL] [Abstract][Full Text] [Related]